Natixis’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.1M | Buy |
80,805
+5,178
| +7% | +$369K | 0.02% | 397 |
|
|
2025
Q4 | $4.67M | Sell |
75,627
-12,183
| -14% | -$717K | 0.02% | 477 |
|
|
2025
Q3 | $5.16M | Sell |
87,810
-4,759
| -5% | -$277K | 0.02% | 430 |
|
|
2025
Q2 | $5.39M | Sell |
92,569
-15,253
| -14% | -$862K | 0.02% | 342 |
|
|
2025
Q1 | $5.34M | Buy |
107,822
+6,014
| +6% | +$308K | 0.03% | 297 |
|
|
2024
Q4 | $4.56M | Buy |
101,808
+18,521
| +22% | +$879K | 0.03% | 355 |
|
|
2024
Q3 | $4M | Buy |
83,287
+3,367
| +4% | +$162K | 0.02% | 342 |
|
|
2024
Q2 | $4.07M | Buy |
79,920
+48,430
| +154% | +$2.65M | 0.02% | 317 |
|
|
2024
Q1 | $1.71M | Buy |
31,490
+26,401
| +519% | +$1.38M | 0.01% | 457 |
|
|
2023
Q4 | $287K | Buy |
5,089
+4,020
| +376% | +$227K | ﹤0.01% | 673 |
|
|
2023
Q3 | $66.1K | Sell |
1,069
-150
| -12% | -$9.49K | ﹤0.01% | 808 |
|
|
2023
Q2 | $72K | Buy |
1,219
+126
| +12% | +$8.02K | ﹤0.01% | 820 |
|
|
2023
Q1 | $80.6K | Buy |
+1,093
| New | +$84.3K | ﹤0.01% | 802 |
|
|
2022
Q4 | – | Sell |
-6,480
| Closed | -$550K | – | 1274 |
|
|
2022
Q3 | $550K | Sell |
6,480
-21,591
| -77% | -$1.86M | ﹤0.01% | 874 |
|
|
2022
Q2 | $2.25M | Sell |
28,071
-5,545
| -16% | -$538K | 0.01% | 640 |
|
|
2022
Q1 | $3.49M | Buy |
33,616
+1,681
| +5% | +$139K | 0.01% | 629 |
|
|
2021
Q4 | $2.4M | Buy |
31,935
+6,010
| +23% | +$421K | 0.01% | 729 |
|
|
2021
Q3 | $1.68M | Buy |
25,925
+19,476
| +302% | +$1.19M | 0.01% | 763 |
|
|
2021
Q2 | $391K | Buy |
6,449
+30
| +0.5% | +$1.77K | ﹤0.01% | 754 |
|
|
2021
Q1 | $346K | Sell |
6,419
-3,425
| -35% | -$186K | ﹤0.01% | 990 |
|
|
2020
Q4 | $473K | Buy |
9,844
+1,939
| +25% | +$85.7K | ﹤0.01% | 908 |
|
|
2020
Q3 | $309K | Sell |
7,905
-9,362
| -54% | -$341K | ﹤0.01% | 657 |
|
|
2020
Q2 | $553K | Buy |
17,267
+9,368
| +119% | +$326K | ﹤0.01% | 604 |
|
|
2020
Q1 | $267K | Sell |
7,899
-115
| -1% | -$4.6K | ﹤0.01% | 637 |
|
|
2019
Q4 | $382K | Sell |
8,014
-1,158
| -13% | -$56K | ﹤0.01% | 738 |
|
|
2019
Q3 | $457K | Buy |
9,172
+456
| +5% | +$23.3K | ﹤0.01% | 694 |
|
|
2019
Q2 | $467K | Buy |
8,716
+1,901
| +28% | +$99.3K | ﹤0.01% | 622 |
|
|
2019
Q1 | $358K | Buy |
+6,815
| New | +$355K | ﹤0.01% | 697 |
|
|
2018
Q4 | – | Sell |
-8,405
| Closed | -$485K | – | 788 |
|
|
2018
Q3 | $485K | Sell |
8,405
-7,511
| -47% | -$416K | ﹤0.01% | 634 |
|
|
2018
Q2 | $866K | Buy |
15,916
+8,000
| +101% | +$397K | ﹤0.01% | 629 |
|
|
2018
Q1 | $374K | Buy |
+7,916
| New | +$396K | ﹤0.01% | 705 |
|
Other funds holding NTR
VCM
Natixis's NTR Position: Q1 2026 in Review
Natixis increased its Nutrien (NTR) stake by 6.8% in Q1 2026, buying an estimated $369K and bringing the position to 80,805 shares worth $6.1M. The position accounts for 0.02% of the portfolio, ranked #397.
Natixis first reported a position in NTR in Q1 2018 and has held it in 31 quarters since. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.
- Natixis held 80,805 shares of Nutrien worth $6.1M as of Q1 2026.
- Natixis bought 5,178 Nutrien shares in Q1 2026, an estimated $369K.
- Nutrien made up 0.02% of Natixis's portfolio in Q1 2026, its #397 holding.
- Natixis first reported a position in Nutrien in Q1 2018 and has held it in 31 quarters since.
- 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.
Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.